Publication | Closed Access

A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group

Hematological MalignancyMedicineImmunologyHematologyMyeloid NeoplasiaMultiple MyelomaPharmacotherapyProspective TrialOncologyCancer ResearchPrimary Remission Induction